ATCOR

ATCOR develops innovative medical devices and digital solutions that help identify and reduce the risk of hypertension, cardiovascular disease (CVD), and other related vascular disorders. Early detection with SphygmoCor technology allows clinicians to detect target organ damage and manage cardiovascular disease, Alzheimers, kidney failure, and other vascular diseases. Using SphygmoCor technology, researchers and clinicians are able to collect and assess clinically relevant digital vascular biomarkers to facilitate routine patient monitoring. These measurements shed insight into subclinical changes in the arterial system that demonstrate the efficacy of clinical trial therapies for chronic vascular diseases. Digital vascular biomarkers provide better prognostic and diagnostic information to target interventionscomplementary and additive tostandard brachial blood pressure measurements. For over twenty years, major medical and research institutions have been using SphygmoCor s...